Delivery Order SPE2DB22D1106-SPE2DB25FFGZ3
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $9,523.55 to AmerisourceBergen Drug Corp for the supply of Gvoke HypoGen 2-pack auto-injectors (1 mg/0.2 mL) on August 7, 2025, with an ultimate completion date of August 8, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a small-value transaction within...
- The Defense Logistics Agency awarded a $2,522.44 firm fixed price delivery order to AmerisourceBergen Drug Corp for one package of Gvoke HypoGel 1 mg/0.2 mL auto-injector. The order is set to be completed by August 18, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a small-value transaction within the company's broader federal pharmaceutical supply portfolio. This...
- The Defense Logistics Agency awarded a $2,540.58 firm fixed-price delivery order to AmerisourceBergen Drug Corp for GVOKE HypoOpen 2-pack auto-injectors (1 mg/0.2 mL) on June 2, 2025, with completion targeted for June 3, 2025. The order will be fulfilled from the contractor's Conshohocken, Pennsylvania location. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $29,684.93 to AmerisourceBergen Drug Corp for the supply of GVOKE HypoPin 2-pack auto-injectors (0.5mg/0.1ml) with an ultimate completion date of August 18, 2025. This firm fixed-price, non-set-aside contract was awarded competitively on August 15, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The GVOKE HypoPin is a glucagon emergency injection system used to treat severe hypoglycemia in...
- The Defense Logistics Agency awarded a delivery order valued at $4,087.62 to AmerisourceBergen Drug Corp for GVOKE HypoPen 2-Pack 1 mg/0.2 ml auto-injectors. This competitively awarded, firm fixed-price contract was executed on August 11, 2025, with an ultimate completion date of August 12, 2025. The contract involves delivery to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. No set-aside provisions were utilized for this award. This...
- The Defense Logistics Agency awarded a delivery order valued at $10,850.43 to AmerisourceBergen Drug Corp for GVOKE HypoPen 2-pack auto-injectors (1 mg/0.2 ml). This firm fixed-price, non-set-aside contract was awarded on August 27, 2025, with an ultimate completion date of August 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. GVOKE HypoPen is an emergency glucagon auto-injector used to treat severe hypoglycemia in patients with diabetes. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for GVOKE HypoPen 2-Pack (1 mg/0.2 mL) with a ceiling value of $3,737.84 under a firm fixed price contract type. The delivery order was non-competitive with no set-aside designation and carries an ultimate completion date of August 4, 2025. Performance will be executed at AmerisourceBergen's Conshohocken, Pennsylvania facility, the company's corporate headquarters. This delivery order is issued as a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Gvoke HypoPen 2-pack auto-injectors (1 mg/0.2 mL dosage). This is a firm fixed-price delivery order with a ceiling value of $10,843.19 and an ultimate completion date of August 26, 2025. The award was competitively procured with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of GVOKE HypoGel auto-injectors (2-pack, 1 mg/0.2 ml dosage) with a ceiling value of $1,018.78. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September...
- The Defense Logistics Agency awarded a delivery order valued at $2,207.00 to AmerisourceBergen Drug Corp for GVOKE HypoKit 2-pack auto-injectors (1 mg/0.2 mL) on June 4, 2025, with completion scheduled for June 5, 2025. This non-set-aside, firm fixed-price contract was awarded competitively and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The GVOKE HypoKit is a critical emergency medication delivery system used to treat severe hypoglycemia in...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFGZ3Delivery Order
The Defense Logistics Agency awarded a $21,248.65 firm fixed-price delivery order to AmerisourceBergen Drug Corp for GVOKE HypoGen 2-pack auto-injectors (1 mg/0.2 ml), with an ultimate completion date of September 5, 2025. This non-set-aside competitive award leverages AmerisourceBergen's comprehensive indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product delivery will be performed at AmerisourceBergen's Corporate Office facility in Conshohocken, Pennsylvania. This delivery order represents a routine procurement under the broader Pharmaceutical Prime Vendor Global Program, through which AmerisourceBergen supplies a wide range of brand-name and generic pharmaceutical products, medical devices, vaccines, and specialized healthcare commodities to support military healthcare systems worldwide. The GVOKE HypoGen auto-injector is a critical emergency glucagon treatment used for severe hypoglycemia management within Defense Health Agency operations and other federal healthcare systems served through this primary vendor arrangement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.2k | 9/4/25 |